← FDA Drug Approvals (Drugs@FDA)

REVTORPYK

NDA · New Drug Application · Sponsor: CELCUITY · Approved 2026-07-14

Drug application

FDA Application #

NDA219908

Application type

New Drug Application

Brand name

REVTORPYK

Generic name

Gedatolisib

Active ingredients

GEDATOLISIB

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CELCUITY

First approval

2026-07-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown